The Plasmodium Falciparum Diagnostics Market is likely to mark stellar growth in the upcoming period. The current situation calls for conducive integrated healthcare models that do away with middlemen regarding offering various products and services. Drug manufacturers, hospital systems, PBMs (pharmacy benefit managers), wholesale distributors, hospital systems, medical insurers, and retail pharmacy outlets – are all into the integration of healthcare strategies. This would be how the healthcare vertical function in the upcoming period.
Plasmodium falciparum belongs to the unicellular protozoan parasite family of humans and is considered to be the most fatal species of plasmodium that is responsible for causing malaria in human species. It is transmitted through the bite of female mosquito, also known as the anopheles.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.persistencemarketresearch.com/samples/25927
According to the Proceedings of the National Academy of Sciences, falciparum is responsible for approximately 50% of malaria cases and result in almost 1 million deaths annually. Plasmodium falciparum is also associated with blood cancer known as Burkitt’s lymphoma and therefore, is considered as group 2A carcinogen.
Plasmodium falciparum diagnostics depend on the physical findings and symptoms of the patient. According to the data published by WHO, approximately 2.7 Billion USD were invested in 2016 for disease control and elimination by government authorities and private international investors of malaria-prone nations like Asia-Pacific and Africa.
Plasmodium falciparum diagnostics is highly being taken care of and tremendous researches and innovations are ongoing for developing novel diagnostic tests as malaria is considered to be a medical emergency globally.
Increasing incidence of malaria caused by the plasmodium falciparum is the major factor driving the plasmodium falciparum diagnostics market. Increase in number of researches and investments related to malaria elimination is also boosting the plasmodium falciparum diagnostics market growth globally.
According to the manufacturer’s survey published by WHO for the world malaria report, diagnostic tests, especially rapid diagnostic tests sale increased to 269 million in 2016 from 240 million in 2015, in the WHO African region. Thus, rise in number of manufacturers, growing awareness on malaria and its diagnosis, is expected to contribute to the market growth for plasmodium falciparum diagnostics market during the forecast period.
Pre-Book Right Now for Exclusive Analyst Support @ https://www.persistencemarketresearch.com/checkout/25927
However, less availability of these diagnostic tests in several regions globally might hinder the market growth for plasmodium falciparum diagnostics market. High costs associated with these diagnostic tests and requirement of skilled workforce and specialized laboratories could also hinder the plasmodium falciparum diagnostics market during the forecast period.
|basis of Technology
|basis of end users
Global Plasmodium falciparum Diagnostics market has witnessed growth due to expanding demand for malaria elimination and high awareness about the disease. Several innovations in plasmodium falciparum diagnostics like rapid diagnostic testing are being practiced.
Rapid diagnostic testing includes antigen detection and is considered to be an alternative for the conventional microscopic diagnosis when reliable diagnosis is not available. Strong pipeline for rapid diagnostic testing and availability of different rapid diagnostic tests are expected to contribute to the plasmodium falciparum diagnostics market.
Get a Customized Scope to Match Your Need Ask an Expert- firstname.lastname@example.org
WHO is involved in several initiatives that include scientists and various manufacturers of plasmodium falciparum diagnostics test device for all possibilities of developing sensitive, accurate, efficient and cost-effective diagnostic tests for malaria.
Plasmodium falciparum diagnostics include molecular diagnostic tests which further includes PCR and RT-PCR where blood samples are analyzed. However, microscopy testing is the most popular diagnostic test for plasmodium falciparum detection, owing it to the cost-effectiveness and easy availability of the test.
Geographically, global Plasmodium falciparum Diagnostics market is segmented into regions viz. North America, Latin America, Asia Pacific and the Middle East & Africa, Western Europe, Eastern Europe. Africa’s Plasmodium falciparum Diagnostics market is expanding owing it to the high disease burden of malaria because of socio-economic instability, local weather conditions and poor healthcare systems.
According to the WHO, approximately 91% of deaths globally caused by malaria were recorded in the Africa region. India, in the Asia-Pacific region is expected to have a major share in the plasmodium falciparum diagnostics market. Europe’s plasmodium falciparum diagnostics market and North America market for plasmodium falciparum diagnostics is expected to contribute the least, owing it to low prevalence of malaria in the region and high awareness of the disease.
Some of the market participants in the Global Plasmodium falciparum Diagnostics market identified across the value chain include: Abbott Laboratories, Danaher, bioMérieux SA, Siemens AG, Bio-Rad Laboratories, Inc, Leica Microsystems, Nikon Corporation, Sysmex Partec, Olympus Corporation, ZeptoMetrix Corporation and altona Diagnostics GmbH.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
To receive an extensive list of important regions, ask for a Table of Content @ https://www.persistencemarketresearch.com/toc/25927
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Argentina, Mexico, Brazil)
- Europe (Germany, Italy, U.K, Spain, France, Russia, Poland)
- Asia Pacific Excluding Japan (India, Australia & New Zealand, China, ASEAN)
- Middle East and Africa (GCC, South Africa, Rest Of MEA)
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
To receive an extensive list of important regions, ask for a Table of Content @
About Us: – Persistence Market Research
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – email@example.com
Website – https://www.persistencemarketresearch.com
Why pay for news and opinions when you can get them for free?
Subscribe for free now!
By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
FINANCE3 days ago
Backpack Raises $17 Million Strategic Series A Round Led by Placeholder VC
NEWS3 days ago
Record year for wind farms raises hope for EU green energy goals
NEWS3 days ago
Russia diamond producer Alrosa’s annual net profit drops 15.2%
NEWS3 days ago
Swisscom in advanced talks to buy Vodafone Italia for $8.7 billion